ENGINEERING RESILIENCE
How Humberto Guimarães Is Positioning Procurement
as a Strategic Growth Engine at Brainfarma
In a highly regulated and globally interconnected pharmaceutical market, procurement is no longer a transactional function. It is a structural pillar of quality, resilience, and competitive advantage.
At Brainfarma, part of the Hypera Pharma Group, Humberto Guimarães has positioned Procurement at the centre of business performance. With more than 15 years of crossindustry sourcing experience and leadership through 23 mergers and acquisitions, he combines governance discipline with strategic foresight. From establishing a procurement office in China to embedding digital transparency through structured platforms, his approach reflects a broader evolution in how procurement supports innovation, protects patient safety, and enables sustainable growth.
In this in-depth conversation, Humberto shares how Brainfarma’s procurement function balances compliance with agility, builds long-term strategic partnerships, and strengthens Brazil’s access to high-quality pharmaceutical products in an increasingly volatile global environment.
Professional Journey
Could you walk us through your career path and highlight key experiences that led to your current role as Head of Procurement at Brainfarma?
I have over 15 years of experience in strategic sourcing across pharmaceuticals, cosmetics, home and personal care, and food. Throughout that journey, I have managed critical categories including APIs, excipients, packaging, engineering projects, indirect spend, and marketing services.
What shaped me most was transformation. I led procurement teams through more than 23 mergers and acquisitions, capturing synergies, consolidating supplier bases, and harmonising processes while maintaining operational continuity. In those environments, procurement cannot disrupt the business. It must stabilise, integrate, and optimise simultaneously.
Digital transformation has also been central to my leadership. I oversaw the implementation of platforms such as Coupa and Ariba, embedding governance discipline, auditability, and performance visibility into daily operations. Those initiatives were not about installing systems. They were about changing behaviour and elevating procurement’s credibility within the organisation.
Today, one of my most strategic initiatives is establishing a procurement office in China. With China and India representing the world’s most critical API hubs, a permanent regional presence strengthens supply security, negotiation agility, and market intelligence. My focus is building a globally integrated procurement organisation that combines strategic foresight with operational discipline.
Procurement’s Strategic Role
How does Procurement support Brainfarma’s mission of delivering high-quality, safe, innovative products while growing sustainably?
At Brainfarma, Procurement is not an operational support area. It is a strategic control point for quality, continuity, and competitiveness. In a highly regulated pharmaceutical environment, every sourcing decision has a direct impact on patient safety, regulatory integrity, and commercial performance.
Quality discipline sits at the centre of our approach. We enforce strict supplier qualification standards aligned with ANVISA and GMP requirements, supported by structured audits and cross-functional governance with Quality and Regulatory teams. Procurement safeguards product integrity before a material ever reaches the production line.
Resilience is equally fundamental. Brazil remains structurally dependent on imported APIs, particularly from China and India. We mitigate that exposure through multi-sourcing strategies, supplier diversification, and structured risk segmentation across critical categories. The establishment of our procurement office in China represents a structural enhancement of this model, strengthening our agility and leverage at the source of global supply.
Beyond continuity, Procurement also enables innovation and sustainable growth. We engage suppliers early in development cycles, support value engineering initiatives, and embed ESG standards into sourcing frameworks. Growth must be resilient, compliant, and responsible. Procurement ensures that it is.
Innovation in Supply Chain
Brainfarma emphasises innovation in R&D. How do you integrate innovative approaches into procurement processes?
Innovation at Brainfarma does not begin and end in the laboratory. Procurement plays a decisive role in translating scientific ambition into scalable, compliant execution.
We structure our sourcing architecture to balance speed with resilience. Dual and multi-sourcing strategies across APIs and excipients reduce dependency risk while allowing R&D the flexibility to accelerate reformulations or adapt to regulatory changes. Our qualification processes are rigorous, but designed to support agility rather than restrict it.
Brainfarma’s state-of-the-art R&D capability in Brazil is strengthened by global partnerships with CMOs and CDMOs that provide specialised technologies and advanced development platforms. Procurement structures these collaborations with clear intellectual property protection, regulatory safeguards, and long-term commercial clarity, ensuring innovation transitions smoothly into production.
We also prioritise early supplier involvement. By aligning technical specifications, documentation, and manufacturing readiness during development phases, we remove bottlenecks before they appear. Innovation succeeds when governance, visibility, and operational alignment operate together.
Partnerships & Collaborations
How does Procurement strengthen Brainfarma’s portfolio and market presence?
Procurement is directly aligned with how Brainfarma competes in the market. Partnerships are structured according to strategic positioning rather than transactional convenience.
In high-growth or differentiated therapeutic areas, we pursue exclusive licensing and codevelopment agreements that enable early market entry. Procurement ensures supply security, regulatory clarity, and scalable commercial frameworks from the outset.
In competitive markets, we focus on differentiation through formulation enhancement, delivery innovation, or cost optimisation enabled by global sourcing partnerships. These collaborations strengthen brand positioning without compromising compliance.
Where exclusivity is possible, we negotiate preferential or exclusive access to niche molecules and unique combinations, creating defensible portfolio assets. In commoditised segments, disciplined global sourcing ensures cost competitiveness and reliability. Procurement shapes portfolio strength by aligning sourcing strategy with commercial ambition.
From left to right: Ligia Nascimento MRO Itens and International Logistic Manager, Luiz Gustavo Market Intelligence Manager, Luana Baceti CMO Contracts Manager, Humberto Guimaraes Head of Procurement, Thelma Costa Marketing Procurement Anne Cecille Raw Material(APIs and packaging) Manager, Luis Henrique Sourcing Manager, Claudinete Bonilha Indirect Manager
Building together
A SAFER TOMORROW
Because cybersecurity is not just about protecting systems. It is about protecting what moves people forward.
We believe life is built on connections.
Between people. Between systems. Between trust and technology.
In a world powered by invisible clouds, distributed environments and constant change, security is what allows everything to keep moving forward without interruption.
Behind every secure operation and every resilient system, there are people. Talented. Committed. Always present.
Cybersecurity does not start with code.
It starts with awareness, responsibility and partnership.
That is why our mission goes beyond protecting operations. We work side by side with organizations to protect their businesses, their data and the future they are building.
Together. Always There.
A trusted partner for a safer digital future
For over 18 years, NTSec Group has been helping organizations face today’s cybersecurity challenges with confidence and clarity.
We deliver advanced and integrated solutions across network, infrastructure, cloud and data security, combining technology, strategy and people in a single, consistent approach.
Driven by innovation and an unwavering commitment to cyber resilience, we support organizations operating in complex and critical environments. Our work is grounded in deep technical expertise, structured processes and a clear understanding of operational and regulatory demands.
By focusing on visibility, control, availability and data integrity, we help our clients build security environments that are resilient, transparent and aligned with their business objectives.
So they can focus on what matters most: growing their business with confidence and peace of mind.
Building TOGETHER a safer tomorrow
About NTSec Group
With over 18 years of experience dedicated to excellence in cybersecurity, NTSec Group is recognized for delivering advanced and integrated solutions for network, infrastructure, cloud and data security. With a strong culture of innovation and an unwavering commitment to a secure future, NTSec Group offers a comprehensive portfolio of services designed to stay ahead of technological challenges, enabling more than 200 clients to focus on growing their businesses with confidence and peace of mind.
Supplier Relationship & Quality Assurance
What strategies do you employ to foster strong supplier relationships while maintaining strict standards?
In pharmaceuticals, relationships are sustained through discipline and transparency. Trust is reinforced through verification.
We conduct regular on-site engagement across key sourcing regions, particularly in Asia, to observe production practices and quality systems directly. Physical presence strengthens alignment and enables early identification of risk.
Structured audits aligned with ANVISA and GMP requirements verify documentation discipline, traceability, and operational integrity. Corrective actions are formalised and monitored to ensure continuous improvement rather than episodic compliance.
Recent supplier engagement in India, including multiple site visits and direct collaboration with CDMO partners, reinforced the importance of cultural understanding, local presence, and relationship depth in building resilient and forward-looking partnerships.
In packaging, collaboration with specialised partners strengthens traceability systems and anticounterfeiting safeguards, directly protecting patient safety and brand integrity. Strong relationships are built on accountability, not assumption.
Risk Management & Compliance
How does Procurement proactively identify and mitigate risk?
Risk management is embedded within procurement architecture, not applied reactively.
Supplier onboarding operates through defined qualification gates covering GMP readiness, technical capability, documentation discipline, and ethical compliance. Adherence to our Code of Conduct and Anti-Corruption Policy is contractually enforced and auditable.
The implementation of Coupa strengthened governance across the Source-to-Pay cycle, embedding approval logic, policy enforcement, and full audit trails into daily operations. This ensures decisions are structured, traceable, and repeatable.
Ongoing monitoring assesses supplier financial stability, geopolitical exposure, and operational performance. Digital alerts allow proactive intervention before disruption impacts production.
This layered model protects regulatory standing, operational continuity, and patient safety simultaneously.
Global Affinity in Healthcare
We are a globally established group dedicated to the development, production, and commercialization of pharmaceutical raw materials and finished products. With a strong industrial infrastructure and advanced product development centers across South America, Europe, China, and India, we deliver innovative, high-quality solutions to meet the evolving needs of the global healthcare market.
Chemo is part of Insud Pharma, a global group with more than 45 years of history and a solid presence across the entire chemical-pharmaceutical value chain. We operate in the development, production and commercialization of active pharmaceutical ingredients (APIs) and a broad range of finished dosage forms (FDFs), providing comprehensive solutions for multiple therapeutic areas.
With development centers and a robust industrial network located across South America, Europe and India, we operate with state-of-the-art technology, highly qualified teams and strict international quality standards. These pillars support our delivery capabilities and reinforce our commitment to ensuring safety, efficacy and reliability in every product.
The strength of our model lies in vertical integration: we control the process from end to end, from research and development to manufacturing, packaging, registration, regulatory support, logistics and intellectual property. This enables us to ensure predictability, efficiency and full traceability, positioning us as a strategic partner for more than 1,100 pharmaceutical companies in 96 countries.
Our focus is to build long-term relationships based on service, innovation and credibility. We work closely with our clients to provide high-quality generic medicines, developed and manufactured primarily in advanced facilities, with continuous support throughout the entire product lifecycle.
Guided by the purpose of improving people’s health and well-being, we combine global scale, technical expertise and a strong commitment to quality to deliver real value to our partners and to the pharmaceutical sector as a whole.
Technology as a Strategic Enabler
With digital platforms such as Coupa forming part of your procurement infrastructure, how do you leverage technology to drive transparency, collaboration, and performance improvement?
Technology becomes strategic when it enhances judgement and alignment, not simply when it automates transactions.
When we implemented Coupa, the objective was not only to digitise processes or strengthen controls. It was to create a transparent backbone across the Source-to-Pay cycle that connects Procurement, Finance, Quality, and Operations through shared data and structured workflows.
Governance and auditability are essential in a regulated pharmaceutical environment, but the true advantage lies in visibility. Real-time spend analytics, supplier performance tracking, and structured approval hierarchies enable data-driven dialogue rather than assumption-based negotiation.
This transparency strengthens collaboration. Conversations shift from isolated price discussions to broader evaluation of total cost, service reliability, and risk exposure. Technology therefore becomes a catalyst for discipline, alignment, and sustained performance improvement across the ecosystem.
From Transactional to Strategic Partnerships
How do you ensure relationships evolve into long-term value creation?
Strategic partnerships are built through structure, not sentiment.
The foundation begins with clarity of expectations. We define measurable outcomes around resilience, compliance excellence, operational efficiency, and innovation contribution. A relationship becomes strategic when both sides are aligned on delivering against those objectives.
Digital transformation has enabled this evolution by standardising workflows and increasing performance visibility. As integration deepens, cybersecurity governance also becomes critical, with partners supporting structured IT governance and protecting ecosystem integrity within an increasingly connected environment. When governance is clear and data is transparent, dialogue matures. Suppliers are evaluated on their contribution to resilience, innovation, and long-term competitiveness rather than short-term price variance.
Co-Innovation and Measurable Value Creation
How does Brainfarma work with partners to co-create tangible outcomes?
Co-innovation is structured value creation with measurable impact.
In packaging, collaboration with partners extends beyond supply fulfilment. Early engagement in development phases strengthens traceability, compliance precision, and production efficiency while reducing operational risk. On the API side, partnerships are grounded in technical dialogue and capacity alignment. Through multi-sourcing strategies, structured forecasting, and long-term planning, we mitigate volatility while maintaining cost competitiveness and supply continuity.
Early supplier involvement accelerates regulatory documentation, specification alignment, and sourcing readiness, shortening development cycles and reducing bottlenecks. Disciplined governance frameworks ensure that value creation is continuous rather than episodic.
We are the technology and innovation leader in the label market, with a strong focus on sustainable labeling solutions.
Protecting brands, products and patients, by surpassing industry standards with stringent procedures and control measures.
Tamper evident solutions
Aluminum for blisters
Shrink sleeves
Folding boxes
Autoinjector
Doypack
Logistics Resilience Amid Disruption
How has Procurement evolved its logistical strategies for greater resilience?
The pandemic reinforced that resilience must be engineered deliberately.
We elevated Supplier Relationship Management into a strategic discipline, maintaining direct engagement with critical suppliers and formalising contingency planning frameworks. Capacity visibility and scenario planning are embedded in our operating model. Logistics strategies were redesigned for agility. Multi-modal transport options and flexible freight agreements reduce dependency on single routes, while real-time visibility enables proactive intervention.
Brazil’s retail landscape adds complexity. Serving more than 100,000 pharmacies requires close coordination across Procurement, Supply Chain, and Commercial teams to maintain service levels consistently. Resilience is now the result of structured planning, disciplined partnerships, and enhanced visibility.
Talent & Capability Development
How does your procurement team remain current and competitive?
Procurement capability is a strategic asset that requires continuous development.
We conduct regular regulatory training aligned with ANVISA and global standards to ensure compliance remains embedded in daily practice. Ethical governance and anti-corruption frameworks are reinforced through structured programmes. Beyond compliance, we invest in strengthening strategic competencies such as negotiation, category management, cost modelling, and digital fluency. Continuous learning platforms support awareness of global sourcing trends and risk evolution.
Cross-functional collaboration ensures sourcing decisions align with innovation priorities and regulatory requirements. A high-performing procurement organisation is built on knowledge, discipline, and alignment.
Social Responsibility & Inclusion
How does Procurement support Brainfarma’s ESG and community initiatives?
Operating within the Cerrado biome reinforces our responsibility to balance economic performance with environmental stewardship.
ESG criteria are embedded directly into supplier qualification processes. Environmental impact, water stewardship, emissions management, and biodiversity awareness are evaluated alongside technical performance and compliance standards. Procurement prioritises sustainable packaging solutions, green chemistry initiatives, and waste reduction programmes that extend Brainfarma’s environmental commitment across the value chain.
We also encourage supplier participation in youth development and apprenticeship initiatives, strengthening local talent pipelines and community inclusion. Sustainable growth requires alignment between operational excellence and social responsibility.
Across distribution, contract manufacturing, and product development, Molkem brings a unified approach to the pharmaceutical value chain, simplifying complexity through a single-window model.
Advancing as a Global Pharmaceutical & R&D Partner
From Indian Roots to a Global Pharma Footprint
Molkem has evolved into a globally integrated pharmaceutical organization, with a presence across 60+ countries and a customer base of over 300 clients. With subsidiaries in Brazil, Mexico, Dubai, and Vietnam, along with regional offices in Argentina and Colombia, Molkem maintains strong proximity to key markets. Its growing footprint in Brazil reflects a focused commitment to one of the most dynamic pharmaceutical ecosystems globally.
Strengthening Identity as R&D driven organization
Building on this global reach, Molkem is strengthening its foundation in scientific and innovation driven capabilities. Molkem Labs serves as the company’s R&D engine, integrating formulation development, analytical development, and dossier preparation. By combining API intelligence with formulation science, Molkem develops bioequivalent, ready to scale prototypes supported by robust characterization. This approach de-risks development and accelerates commercialization through Tech Transfer, CDMO and out-licensing pathways, enabling faster and more reliable market entry.
Strategic Alliance with Brainfarma
A key growth driver in the Brazilian market has been Molkem’s long-standing and evolving partnership with Brainfarma. What began as a supply relationship has matured into a strategic collaboration encompassing product development, regulatory support, and pipeline expansion. Today, the partnership reflects a shared platform for value creation, innovation, and long-term growth.
Reliability in a Complex Supply Chain
Complementing its scientific capabilities, Molkem anchors reliability through a tightly integrated operating model which combines global sourcing, agile execution, and local market presence. This enables the company to deliver demand driven solutions while remaining responsive during critical moments.
The API+ Advantage
This integrated model is anchored in Molkem’s API+ approach, which bridges API expertise with formulation development. By creating scalable formulations supported by comprehensive documentation and seamless technology transfer, Molkem helps partners reduce development timelines and mitigate technical risk.
Built on Trust, Driven by Execution
At its core, Molkem’s journey is built on trust, transparency, and disciplined execution ensuring sustainable partnerships and long term success across global pharmaceutical markets.
Governance, Performance and Trust
How do you balance governance with flexibility for innovation?
Governance creates the environment in which trust can develop.
Structured workflows, auditability, and policy enforcement provide predictability and transparency. Digital governance ensures procurement decisions are traceable and consistent.
Clear KPIs and structured performance reviews provide discipline without restricting dialogue. When expectations are visible and data-driven, suppliers are more confident proposing innovation within defined boundaries.
Flexibility exists within structure. Strong governance enables responsible innovation rather than limiting it.
Building a Future-Ready Procurement Ecosystem
What defines the ideal strategic partner for Brainfarma?
The ideal strategic partner combines resilience, innovation capability, governance maturity, and ESG alignment.
Future ecosystems must operate with shared data, proactive risk visibility, and continuous improvement discipline. Partners should invest in operational reliability, technological advancement, and sustainable practices.
Digital transparency and performance accountability are fundamental. Collaboration must be supported by measurable outcomes rather than informal alignment. Procurement’s role is to curate a partner network that reinforces competitiveness, compliance, and long-term sustainability.
Strategic Priorities Ahead
What are your top priorities for Procurement over the next five years?
Our priorities remain clear: strengthen resilience, deepen quality discipline, accelerate innovation enablement, and embed sustainability into sourcing decisions. We are advancing structured risk mapping across critical APIs, expanding dual-sourcing frameworks, and reinforcing supplier audit programmes to protect continuity and regulatory integrity.
Exclusive partnerships and early-stage collaboration with innovation partners will continue to support differentiated portfolio growth. Digital analytics and performance monitoring will further enhance decision quality and visibility. Every procurement decision must reinforce Brainfarma’s mission to expand access to safe, high-quality, innovative healthcare while ensuring sustainable and responsible growth.
Operational Excellence, Sustainable Growth and a Vision That Orchestrates the Future
Procurement Garage (PG) is one of the world most important consultancy firms, specialized in procurement, supply chain, operations, logistics and applied technologies operating across Brazil, Mexico, the United States, Europe and Asia.
We combine strategy with hands-on delivery to connect vision and execution. Our approach prioritizes quick wins, clear performance metrics and structured roadmaps.
A Coupa Global Strategic Partner, PG was named Best LATAM Partner (2024, 2025) and has delivered projects in 20+ countries. We have also been recognized by the Procurement Leaders Awards and the Procurement & Supply Chain Awards (2024, 2025).
2ND BEST PROCUREMENT Consultancies
For 2026, PG advances as a true value orchestrator connecting People, Strategy & Planning, Procurement & SRM, Operations & Production, Logistics & Distribution, and Technology to drive measurable performance across the entire value chain.
Backed by a senior expert team and a global partner ecosystem, PG accelerates efficiency,resilience, innovation and sustainable growth from planning to execution.
Mexico, the USA, Europe, and Asia
Geopolitical Risk & Supply Chain Resilience
Geopolitical Risk & Supply Chain Resilience: How does the current conflict in the Middle East impact pharmaceutical supply chains, and what is the role of Procurement in navigating this environment?
The ongoing conflict in the Middle East reinforces a reality that Procurement leaders in pharmaceuticals have been managing for some time: supply chain risk today is systemic, interconnected, and rarely confined to a single geography. A significant portion of pharmaceutical synthesis routes depend on solvents and intermediates derived from petroleum. Disruptions in oil production, refining capacity, maritime routes, or energy pricing have a direct and immediate impact on the availability and cost of critical raw materials. In recent months, several suppliers have already signaled potential shortages or allocation risks for key solvents, highlighting how geopolitical tensions can rapidly translate into operational exposure for the industry.
In this context, the role of Procurement goes far beyond price negotiation. It is fundamentally about resilience engineering. This means anticipating risk across multiple layers—geopolitical, logistical, financial, regulatory, and technical—and building structural responses before disruption materializes.
At Brainfarma, resilience is addressed through diversification of supply sources across Asia and Europe, multi-sourcing strategies for critical APIs and excipients, and deep, transparent collaboration with strategic suppliers. Many of our partners are operating under the same uncertainty, and navigating these moments successfully requires trust, open communication, and joint scenario planning rather than transactional behavior.
Our experience during the pandemic reinforced this mindset. Companies that treated suppliers as interchangeable vendors struggled. Those that acted as partners preserved continuity. The same principle applies today. By maintaining close relationships, early visibility into supplier constraints, and disciplined risk segmentation, we are able to mitigate impacts and protect our operations without compromising quality or patient safety.
Ultimately, geopolitical volatility has elevated Procurement into a core leadership function. Decisions made in sourcing directly influence production continuity, regulatory compliance, and market access. In an environment where many suppliers are concentrated in Asia and Europe and global tensions remain high, Procurement leadership is about ensuring stability, adaptability, and long-term value creation—especially when the external environment is anything but stable.
Brainfarma, part of the Hypera Pharma group, is a leading pharmaceutical manufacturer in Brazil, specialising in the production of medicines across multiple therapeutic areas. The company operates one of the largest pharmaceutical manufacturing facilities in Latin America, focusing on innovation, quality and operational excellence to deliver accessible healthcare solutions to patients across the region.
Humberto Guimaraes Head of Procurement